Rank | Gene Set | Z-score |
---|---|---|
1 | * NIK/NF-kappaB signaling (GO:0038061) | 5.12721934 |
2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.07785346 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.96965479 |
4 | regulation of response to tumor cell (GO:0002834) | 4.87835334 |
5 | positive regulation of response to tumor cell (GO:0002836) | 4.87835334 |
6 | positive regulation of immune response to tumor cell (GO:0002839) | 4.87835334 |
7 | regulation of immune response to tumor cell (GO:0002837) | 4.87835334 |
8 | activated T cell proliferation (GO:0050798) | 4.87460085 |
9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.55455775 |
10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.55131213 |
11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.55131213 |
12 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.45253116 |
13 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.39882926 |
14 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.27302414 |
15 | negative regulation of interleukin-12 production (GO:0032695) | 4.26912775 |
16 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.20814277 |
17 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.20814277 |
18 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.20426774 |
19 | negative regulation of cell killing (GO:0031342) | 4.19003115 |
20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.19003115 |
21 | myeloid dendritic cell differentiation (GO:0043011) | 4.11843101 |
22 | myeloid dendritic cell activation (GO:0001773) | 4.05300273 |
23 | response to muramyl dipeptide (GO:0032495) | 4.01534289 |
24 | neutrophil activation involved in immune response (GO:0002283) | 3.96291265 |
25 | immunoglobulin mediated immune response (GO:0016064) | 3.87950697 |
26 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.86325404 |
27 | negative thymic T cell selection (GO:0045060) | 3.83394724 |
28 | cellular response to interleukin-15 (GO:0071350) | 3.82104236 |
29 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.79923765 |
30 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.78510665 |
31 | positive regulation by symbiont of host defense response (GO:0052509) | 3.77941179 |
32 | modulation by symbiont of host defense response (GO:0052031) | 3.77941179 |
33 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.77941179 |
34 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.77941179 |
35 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.77941179 |
36 | modulation by symbiont of host immune response (GO:0052553) | 3.77941179 |
37 | negative regulation of T cell mediated immunity (GO:0002710) | 3.72272973 |
38 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.71215795 |
39 | regulation of gamma-delta T cell activation (GO:0046643) | 3.66596347 |
40 | positive regulation of antigen processing and presentation (GO:0002579) | 3.66494588 |
41 | negative T cell selection (GO:0043383) | 3.64121785 |
42 | regulation of chronic inflammatory response (GO:0002676) | 3.62684792 |
43 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.61445457 |
44 | positive regulation of humoral immune response (GO:0002922) | 3.58880900 |
45 | positive regulation of cell killing (GO:0031343) | 3.57174316 |
46 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.54544495 |
47 | regulation of cell killing (GO:0031341) | 3.54253863 |
48 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.50095351 |
49 | positive regulation of tolerance induction (GO:0002645) | 3.49360110 |
50 | response to peptidoglycan (GO:0032494) | 3.49234335 |
51 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.49192501 |
52 | neutrophil activation (GO:0042119) | 3.48545458 |
53 | positive regulation of interleukin-12 production (GO:0032735) | 3.48048295 |
54 | positive regulation of interleukin-10 production (GO:0032733) | 3.47510905 |
55 | positive thymic T cell selection (GO:0045059) | 3.45575980 |
56 | positive regulation of protein homooligomerization (GO:0032464) | 3.43708356 |
57 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.42753885 |
58 | natural killer cell mediated immunity (GO:0002228) | 3.39230571 |
59 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.39230571 |
60 | positive regulation of interferon-alpha production (GO:0032727) | 3.37985905 |
61 | response to type I interferon (GO:0034340) | 3.37906547 |
62 | cellular response to type I interferon (GO:0071357) | 3.37819420 |
63 | type I interferon signaling pathway (GO:0060337) | 3.37819420 |
64 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.36608539 |
65 | regulation of tolerance induction (GO:0002643) | 3.35972418 |
66 | granulocyte activation (GO:0036230) | 3.34045591 |
67 | regulation of regulatory T cell differentiation (GO:0045589) | 3.33002816 |
68 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.31806503 |
69 | positive regulation of B cell differentiation (GO:0045579) | 3.31729042 |
70 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.30825647 |
71 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.29043730 |
72 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.28279312 |
73 | tolerance induction (GO:0002507) | 3.27472823 |
74 | regulation of interferon-alpha production (GO:0032647) | 3.25985323 |
75 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.25471338 |
76 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.24484835 |
77 | positive regulation of interleukin-2 production (GO:0032743) | 3.23720502 |
78 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.22856775 |
79 | dendritic cell differentiation (GO:0097028) | 3.20584917 |
80 | regulation of T-helper cell differentiation (GO:0045622) | 3.18595328 |
81 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.16485899 |
82 | positive regulation of type 2 immune response (GO:0002830) | 3.16151168 |
83 | regulation of antigen processing and presentation (GO:0002577) | 3.13516748 |
84 | * regulation of RIG-I signaling pathway (GO:0039535) | 3.13209865 |
85 | T cell costimulation (GO:0031295) | 3.13027558 |
86 | lymphocyte costimulation (GO:0031294) | 3.11516686 |
87 | T cell migration (GO:0072678) | 3.11245830 |
88 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.10371030 |
89 | regulation of hypersensitivity (GO:0002883) | 3.10161763 |
90 | T cell mediated immunity (GO:0002456) | 3.10161232 |
91 | interferon-gamma production (GO:0032609) | 3.09437195 |
92 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.08964809 |
93 | regulation of interleukin-10 production (GO:0032653) | 3.08772010 |
94 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.08516321 |
95 | regulation of B cell differentiation (GO:0045577) | 3.07915653 |
96 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.07338473 |
97 | germinal center formation (GO:0002467) | 3.06982024 |
98 | defense response to protozoan (GO:0042832) | 3.06953344 |
99 | T cell proliferation (GO:0042098) | 3.04904823 |
100 | regulation of response to interferon-gamma (GO:0060330) | 3.04891566 |
101 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.04621057 |
102 | positive regulation of T cell chemotaxis (GO:0010820) | 3.01997018 |
103 | regulation of T cell chemotaxis (GO:0010819) | 3.01997018 |
104 | regulation of interleukin-12 production (GO:0032655) | 3.01627046 |
105 | production of molecular mediator of immune response (GO:0002440) | 3.01273450 |
106 | thymic T cell selection (GO:0045061) | 3.00668855 |
107 | regulation of immunoglobulin secretion (GO:0051023) | 2.99702044 |
108 | macrophage activation involved in immune response (GO:0002281) | 2.99152474 |
109 | B cell mediated immunity (GO:0019724) | 2.98604960 |
110 | T cell lineage commitment (GO:0002360) | 2.98472291 |
111 | positive regulation of immunoglobulin production (GO:0002639) | 2.97765140 |
112 | mature B cell differentiation (GO:0002335) | 2.97551222 |
113 | positive T cell selection (GO:0043368) | 2.97426135 |
114 | B cell receptor signaling pathway (GO:0050853) | 2.97391392 |
115 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.95723125 |
116 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.94881148 |
117 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.94281045 |
118 | positive regulation of interleukin-17 production (GO:0032740) | 2.94151777 |
119 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.91159008 |
120 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.89812304 |
121 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.84656260 |
122 | T cell selection (GO:0045058) | 2.84567018 |
123 | positive regulation of defense response to virus by host (GO:0002230) | 2.84440987 |
124 | leukocyte aggregation (GO:0070486) | 2.83776511 |
125 | response to protozoan (GO:0001562) | 2.82821429 |
126 | positive regulation of interferon-beta production (GO:0032728) | 2.82589494 |
127 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.80593581 |
128 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.80427180 |
129 | T-helper cell differentiation (GO:0042093) | 2.80427180 |
130 | cellular response to zinc ion (GO:0071294) | 2.78048246 |
131 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.77330011 |
132 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.75725074 |
133 | regulation of activation of Janus kinase activity (GO:0010533) | 2.73733932 |
134 | respiratory burst (GO:0045730) | 2.73659405 |
135 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.73630667 |
136 | cytokine secretion (GO:0050663) | 2.70792603 |
137 | hepatocyte apoptotic process (GO:0097284) | 2.70549717 |
138 | response to interleukin-15 (GO:0070672) | 2.69602699 |
139 | B cell homeostasis (GO:0001782) | 2.68007543 |
140 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.67577680 |
141 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.67503772 |
142 | myeloid cell activation involved in immune response (GO:0002275) | 2.67422496 |
143 | regulation of T cell tolerance induction (GO:0002664) | 2.67420846 |
144 | T-helper 1 type immune response (GO:0042088) | 2.66468282 |
145 | leukocyte mediated cytotoxicity (GO:0001909) | 2.66226095 |
146 | response to host (GO:0075136) | 2.65231390 |
147 | response to host defenses (GO:0052200) | 2.65231390 |
148 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.65231390 |
149 | response to host immune response (GO:0052572) | 2.64841190 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.02956826 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.55602260 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.18444584 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.68511808 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.32693860 |
6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.11624853 |
7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.80487112 |
8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.52692053 |
9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.47602688 |
10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.24998714 |
11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.17845219 |
12 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.16969837 |
13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.08746997 |
14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.94532379 |
15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.78432556 |
16 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.75514537 |
17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.74649309 |
18 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.74542279 |
19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.67559959 |
20 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.63752550 |
21 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.58358602 |
22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.52813547 |
23 | MYB_26560356_Chip-Seq_TH2_Human | 2.40309082 |
24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.35776423 |
25 | MYB_26560356_Chip-Seq_TH1_Human | 2.05495304 |
26 | * MAF_26560356_Chip-Seq_TH1_Human | 1.90439087 |
27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.90328880 |
28 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.77176526 |
29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.76621911 |
30 | MYC_22102868_ChIP-Seq_BL_Human | 1.75758474 |
31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.74988388 |
32 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.67793320 |
33 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.62936192 |
34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62439234 |
35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.60017979 |
36 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.59847687 |
37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.59472177 |
38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.55748832 |
39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.52911822 |
40 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.52855951 |
41 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52442151 |
42 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.52384164 |
43 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.51737116 |
44 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.50327954 |
45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49616451 |
46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.45538999 |
47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.44724957 |
48 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.42850938 |
49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42583714 |
50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41620868 |
51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39482683 |
52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.37096298 |
53 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36922858 |
54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36479442 |
55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29173263 |
56 | GATA3_26560356_Chip-Seq_TH2_Human | 1.25197502 |
57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22142266 |
58 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15184012 |
59 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14697483 |
60 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08775900 |
61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08279396 |
62 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07820102 |
63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07232137 |
64 | MAF_26560356_Chip-Seq_TH2_Human | 1.05818813 |
65 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.04749754 |
66 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04350028 |
67 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.02341777 |
68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01596011 |
69 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01346413 |
70 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.01020419 |
71 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.97835214 |
72 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97720856 |
73 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93179161 |
74 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93001660 |
75 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.92769840 |
76 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90481545 |
77 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.88239671 |
78 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87890342 |
79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87525922 |
80 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85832745 |
81 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.85535972 |
82 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.85141682 |
83 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.83594420 |
84 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.80599463 |
85 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.79464410 |
86 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.79204007 |
87 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.76533236 |
88 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75398902 |
89 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.75219166 |
90 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75024021 |
91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.74858390 |
92 | GATA2_19941826_ChIP-Seq_K562_Human | 0.74081185 |
93 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.73481353 |
94 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.73130052 |
95 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73016856 |
96 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.72432995 |
97 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.72432995 |
98 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.71700860 |
99 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.70631090 |
100 | * SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.69980998 |
101 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69025229 |
102 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68649129 |
103 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.67529827 |
104 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67357882 |
105 | GATA1_19941826_ChIP-Seq_K562_Human | 0.67090595 |
106 | GATA3_26560356_Chip-Seq_TH1_Human | 0.66987203 |
107 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66756811 |
108 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.66374586 |
109 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.65971235 |
110 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.65560674 |
111 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.65177729 |
112 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65110176 |
113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.64781914 |
114 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64748390 |
115 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.63463193 |
116 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.62986734 |
117 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.62818984 |
118 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.62304709 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.60917233 |
2 | MP0000685_abnormal_immune_system | 3.75500056 |
3 | MP0005387_immune_system_phenotype | 3.29722435 |
4 | MP0001790_abnormal_immune_system | 3.29722435 |
5 | MP0009785_altered_susceptibility_to | 3.12071448 |
6 | MP0001800_abnormal_humoral_immune | 3.10459445 |
7 | MP0002138_abnormal_hepatobiliary_system | 3.07250961 |
8 | MP0005671_abnormal_response_to | 3.03199611 |
9 | MP0004510_myositis | 2.99938291 |
10 | MP0005000_abnormal_immune_tolerance | 2.93736255 |
11 | MP0003436_decreased_susceptibility_to | 2.87216670 |
12 | MP0002254_reproductive_system_inflammat | 2.78306861 |
13 | * MP0002452_abnormal_antigen_presenting | 2.73069348 |
14 | MP0002148_abnormal_hypersensitivity_rea | 2.70536540 |
15 | * MP0002723_abnormal_immune_serum | 2.58596089 |
16 | MP0005025_abnormal_response_to | 2.48306563 |
17 | * MP0002419_abnormal_innate_immunity | 2.45815664 |
18 | MP0003763_abnormal_thymus_physiology | 2.44080507 |
19 | MP0003303_peritoneal_inflammation | 2.44030584 |
20 | * MP0001819_abnormal_immune_cell | 2.37331283 |
21 | * MP0002420_abnormal_adaptive_immunity | 2.36837879 |
22 | MP0005310_abnormal_salivary_gland | 2.29071078 |
23 | MP0006082_CNS_inflammation | 2.22209546 |
24 | MP0003724_increased_susceptibility_to | 2.14453469 |
25 | MP0002166_altered_tumor_susceptibility | 2.12757817 |
26 | MP0002006_tumorigenesis | 2.10274821 |
27 | MP0001873_stomach_inflammation | 2.09318207 |
28 | MP0002405_respiratory_system_inflammati | 2.04441622 |
29 | MP0002398_abnormal_bone_marrow | 2.02918438 |
30 | MP0010155_abnormal_intestine_physiology | 1.94873306 |
31 | MP0004947_skin_inflammation | 1.94188923 |
32 | * MP0000716_abnormal_immune_system | 1.93159141 |
33 | MP0001853_heart_inflammation | 1.90395163 |
34 | * MP0001845_abnormal_inflammatory_respons | 1.73621471 |
35 | MP0002396_abnormal_hematopoietic_system | 1.72203542 |
36 | MP0002139_abnormal_hepatobiliary_system | 1.71963193 |
37 | MP0000689_abnormal_spleen_morphology | 1.66185746 |
38 | MP0003300_gastrointestinal_ulcer | 1.65482593 |
39 | MP0009333_abnormal_splenocyte_physiolog | 1.64225395 |
40 | MP0000569_abnormal_digit_pigmentation | 1.62058085 |
41 | MP0005464_abnormal_platelet_physiology | 1.59708032 |
42 | MP0002877_abnormal_melanocyte_morpholog | 1.55983600 |
43 | * MP0002429_abnormal_blood_cell | 1.55685238 |
44 | MP0002722_abnormal_immune_system | 1.53963735 |
45 | MP0001533_abnormal_skeleton_physiology | 1.48882615 |
46 | MP0009278_abnormal_bone_marrow | 1.38813267 |
47 | MP0009764_decreased_sensitivity_to | 1.37681957 |
48 | MP0003448_altered_tumor_morphology | 1.32159356 |
49 | MP0005379_endocrine/exocrine_gland_phen | 1.31731019 |
50 | MP0008469_abnormal_protein_level | 1.31188560 |
51 | MP0005397_hematopoietic_system_phenotyp | 1.29473308 |
52 | MP0001545_abnormal_hematopoietic_system | 1.29473308 |
53 | MP0005451_abnormal_body_composition | 1.24458679 |
54 | MP0005166_decreased_susceptibility_to | 1.24350536 |
55 | MP0000703_abnormal_thymus_morphology | 1.24269800 |
56 | MP0004808_abnormal_hematopoietic_stem | 1.21800310 |
57 | MP0001348_abnormal_lacrimal_gland | 1.19602547 |
58 | MP0003453_abnormal_keratinocyte_physiol | 1.16470595 |
59 | MP0001851_eye_inflammation | 1.13159608 |
60 | MP0002277_abnormal_respiratory_mucosa | 1.11810721 |
61 | MP0002009_preneoplasia | 1.11538799 |
62 | MP0002933_joint_inflammation | 1.09770459 |
63 | MP0000858_altered_metastatic_potential | 1.04603270 |
64 | MP0005076_abnormal_cell_differentiation | 1.04126060 |
65 | MP0004381_abnormal_hair_follicle | 1.01468974 |
66 | MP0002163_abnormal_gland_morphology | 0.99543163 |
67 | MP0000490_abnormal_crypts_of | 0.99397406 |
68 | MP0005174_abnormal_tail_pigmentation | 0.97328753 |
69 | MP0002876_abnormal_thyroid_physiology | 0.97325811 |
70 | MP0010352_gastrointestinal_tract_polyps | 0.95399824 |
71 | MP0002998_abnormal_bone_remodeling | 0.94520884 |
72 | MP0001346_abnormal_lacrimal_gland | 0.93971843 |
73 | MP0000343_altered_response_to | 0.93145594 |
74 | MP0003866_abnormal_defecation | 0.91506149 |
75 | MP0003091_abnormal_cell_migration | 0.90764837 |
76 | MP0002019_abnormal_tumor_incidence | 0.86057718 |
77 | MP0003183_abnormal_peptide_metabolism | 0.85574838 |
78 | MP0005058_abnormal_lysosome_morphology | 0.84874093 |
79 | MP0010307_abnormal_tumor_latency | 0.84057418 |
80 | MP0003191_abnormal_cellular_cholesterol | 0.83539813 |
81 | MP0009840_abnormal_foam_cell | 0.82035636 |
82 | MP0003075_altered_response_to | 0.80168184 |
83 | MP0009763_increased_sensitivity_to | 0.77736409 |
84 | MP0000465_gastrointestinal_hemorrhage | 0.77000827 |
85 | MP0008057_abnormal_DNA_replication | 0.76553899 |
86 | MP0005390_skeleton_phenotype | 0.74246663 |
87 | MP0004782_abnormal_surfactant_physiolog | 0.74026015 |
88 | MP0005360_urolithiasis | 0.68555287 |
89 | MP0000249_abnormal_blood_vessel | 0.67524229 |
90 | MP0003045_fibrosis | 0.67259491 |
91 | MP0002136_abnormal_kidney_physiology | 0.66669719 |
92 | MP0003252_abnormal_bile_duct | 0.65834723 |
93 | MP0000767_abnormal_smooth_muscle | 0.65665562 |
94 | MP0008961_abnormal_basal_metabolism | 0.65255959 |
95 | MP0002693_abnormal_pancreas_physiology | 0.63941153 |
96 | MP0005167_abnormal_blood-brain_barrier | 0.63561958 |
97 | MP0003195_calcinosis | 0.63230343 |
98 | MP0009765_abnormal_xenobiotic_induced | 0.63021945 |
99 | MP0000371_diluted_coat_color | 0.61952662 |
100 | MP0000604_amyloidosis | 0.61856249 |
101 | MP0002928_abnormal_bile_duct | 0.61094677 |
102 | MP0001663_abnormal_digestive_system | 0.59028076 |
103 | MP0005023_abnormal_wound_healing | 0.58408312 |
104 | MP0008260_abnormal_autophagy | 0.58378668 |
105 | MP0000609_abnormal_liver_physiology | 0.57134217 |
106 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.56834235 |
107 | MP0008004_abnormal_stomach_pH | 0.56549525 |
108 | MP0003806_abnormal_nucleotide_metabolis | 0.56349554 |
109 | MP0001666_abnormal_nutrient_absorption | 0.56140742 |
110 | MP0001881_abnormal_mammary_gland | 0.55359815 |
111 | MP0003693_abnormal_embryo_hatching | 0.55211223 |
112 | MP0001216_abnormal_epidermal_layer | 0.54762422 |
113 | MP0003077_abnormal_cell_cycle | 0.54639719 |
114 | MP0005164_abnormal_response_to | 0.54491087 |
115 | MP0003566_abnormal_cell_adhesion | 0.54372040 |
116 | MP0005075_abnormal_melanosome_morpholog | 0.53119631 |
117 | MP0001119_abnormal_female_reproductive | 0.52988096 |
118 | MP0001915_intracranial_hemorrhage | 0.52976225 |
119 | MP0003172_abnormal_lysosome_physiology | 0.52551135 |
120 | MP0009115_abnormal_fat_cell | 0.51373644 |
121 | MP0009643_abnormal_urine_homeostasis | 0.49751020 |
122 | MP0003656_abnormal_erythrocyte_physiolo | 0.46915966 |
123 | MP0003795_abnormal_bone_structure | 0.46737327 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 5.63709336 |
2 | Recurrent abscess formation (HP:0002722) | 5.52111881 |
3 | Recurrent bacterial skin infections (HP:0005406) | 5.32421476 |
4 | Myositis (HP:0100614) | 4.84235831 |
5 | Retrobulbar optic neuritis (HP:0100654) | 4.71189742 |
6 | Optic neuritis (HP:0100653) | 4.71189742 |
7 | Recurrent fungal infections (HP:0002841) | 4.67683907 |
8 | Orchitis (HP:0100796) | 4.49978994 |
9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.31225760 |
10 | Recurrent viral infections (HP:0004429) | 4.28638919 |
11 | Recurrent skin infections (HP:0001581) | 3.95469289 |
12 | Vasculitis (HP:0002633) | 3.93825293 |
13 | Recurrent cutaneous fungal infections (HP:0011370) | 3.80366042 |
14 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.80366042 |
15 | Autoimmune thrombocytopenia (HP:0001973) | 3.80025692 |
16 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.72935895 |
17 | Stomatitis (HP:0010280) | 3.70750052 |
18 | * Mediastinal lymphadenopathy (HP:0100721) | 3.67336024 |
19 | Agammaglobulinemia (HP:0004432) | 3.61707885 |
20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.50046061 |
21 | Chronic otitis media (HP:0000389) | 3.42438064 |
22 | IgM deficiency (HP:0002850) | 3.41649967 |
23 | Abnormality of macrophages (HP:0004311) | 3.36875344 |
24 | Abnormality of the fingertips (HP:0001211) | 3.35439284 |
25 | Cellulitis (HP:0100658) | 3.32911399 |
26 | Meningitis (HP:0001287) | 3.29405009 |
27 | Keratoconjunctivitis (HP:0001096) | 3.29340406 |
28 | Recurrent bronchitis (HP:0002837) | 3.27021371 |
29 | Gastrointestinal stroma tumor (HP:0100723) | 3.23742468 |
30 | * Pulmonary infiltrates (HP:0002113) | 3.15040735 |
31 | Increased IgM level (HP:0003496) | 3.14340691 |
32 | Gingivitis (HP:0000230) | 3.11701483 |
33 | Colitis (HP:0002583) | 3.10742480 |
34 | Gastrointestinal infarctions (HP:0005244) | 3.08857431 |
35 | Leukocytosis (HP:0001974) | 3.08020992 |
36 | Arterial thrombosis (HP:0004420) | 3.06356147 |
37 | Keratoconjunctivitis sicca (HP:0001097) | 3.04435405 |
38 | Eosinophilia (HP:0001880) | 3.03383759 |
39 | Pustule (HP:0200039) | 3.00276104 |
40 | IgA deficiency (HP:0002720) | 2.97447204 |
41 | Prostate neoplasm (HP:0100787) | 2.96682857 |
42 | Periodontitis (HP:0000704) | 2.95738555 |
43 | Abnormality of T cell number (HP:0011839) | 2.93078171 |
44 | Abnormality of eosinophils (HP:0001879) | 2.89118405 |
45 | Inflammation of the large intestine (HP:0002037) | 2.85642866 |
46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.83536927 |
47 | Obstructive lung disease (HP:0006536) | 2.83536927 |
48 | Panhypogammaglobulinemia (HP:0003139) | 2.79782315 |
49 | Interstitial pulmonary disease (HP:0006530) | 2.77292150 |
50 | IgG deficiency (HP:0004315) | 2.76080027 |
51 | Increased IgE level (HP:0003212) | 2.72871481 |
52 | Granulocytopenia (HP:0001913) | 2.72687147 |
53 | Nasal polyposis (HP:0100582) | 2.71233150 |
54 | Osteomyelitis (HP:0002754) | 2.69006083 |
55 | Gangrene (HP:0100758) | 2.65330647 |
56 | Abnormality of T cells (HP:0002843) | 2.65159024 |
57 | Hematochezia (HP:0002573) | 2.62036711 |
58 | Abnormality of T cell physiology (HP:0011840) | 2.61954184 |
59 | Gastrointestinal inflammation (HP:0004386) | 2.61891204 |
60 | Hemoptysis (HP:0002105) | 2.59987969 |
61 | T lymphocytopenia (HP:0005403) | 2.59947744 |
62 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.59597994 |
63 | Lymphopenia (HP:0001888) | 2.59061849 |
64 | Thrombocytosis (HP:0001894) | 2.58250331 |
65 | Emphysema (HP:0002097) | 2.53216302 |
66 | Chronic diarrhea (HP:0002028) | 2.52495424 |
67 | Recurrent pneumonia (HP:0006532) | 2.52377697 |
68 | Fatigue (HP:0012378) | 2.50822275 |
69 | Thyroiditis (HP:0100646) | 2.46432715 |
70 | Abnormality of the prostate (HP:0008775) | 2.46128964 |
71 | Abnormality of the nasal mucosa (HP:0000433) | 2.43009475 |
72 | Myocardial infarction (HP:0001658) | 2.42378982 |
73 | Encephalitis (HP:0002383) | 2.41728907 |
74 | Combined immunodeficiency (HP:0005387) | 2.38185784 |
75 | Hypergammaglobulinemia (HP:0010702) | 2.38080487 |
76 | Acute myeloid leukemia (HP:0004808) | 2.35114744 |
77 | Abnormality of the pleura (HP:0002103) | 2.32876234 |
78 | Alveolar cell carcinoma (HP:0006519) | 2.32139502 |
79 | Recurrent lower respiratory tract infections (HP:0002783) | 2.31137553 |
80 | Autoimmune hemolytic anemia (HP:0001890) | 2.30071066 |
81 | Gingival bleeding (HP:0000225) | 2.29450835 |
82 | Recurrent sinusitis (HP:0011108) | 2.26995700 |
83 | Severe combined immunodeficiency (HP:0004430) | 2.25031569 |
84 | Spontaneous hematomas (HP:0007420) | 2.23032372 |
85 | Vacuolated lymphocytes (HP:0001922) | 2.23003903 |
86 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.22340006 |
87 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.22340006 |
88 | Abnormality of glycolipid metabolism (HP:0010969) | 2.22340006 |
89 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.21802783 |
90 | Malnutrition (HP:0004395) | 2.20402786 |
91 | Pulmonary embolism (HP:0002204) | 2.20286088 |
92 | Verrucae (HP:0200043) | 2.19235316 |
93 | Papilloma (HP:0012740) | 2.19235316 |
94 | Loss of speech (HP:0002371) | 2.18026580 |
95 | Urticaria (HP:0001025) | 2.17664404 |
96 | Basal ganglia calcification (HP:0002135) | 2.17642332 |
97 | Joint swelling (HP:0001386) | 2.17605323 |
98 | Hypochromic anemia (HP:0001931) | 2.16674150 |
99 | Bronchitis (HP:0012387) | 2.10165246 |
100 | Thick nail (HP:0001805) | 2.09553285 |
101 | B lymphocytopenia (HP:0010976) | 2.07686744 |
102 | Abnormality of B cell number (HP:0010975) | 2.07686744 |
103 | Skin ulcer (HP:0200042) | 2.06750787 |
104 | Restrictive lung disease (HP:0002091) | 2.03874843 |
105 | Keratitis (HP:0000491) | 2.03064854 |
106 | Chronic sinusitis (HP:0011109) | 2.00927400 |
107 | Viral hepatitis (HP:0006562) | 2.00317425 |
108 | Anorexia (HP:0002039) | 1.99416119 |
109 | Arthralgia (HP:0002829) | 1.99237769 |
110 | Leukopenia (HP:0001882) | 1.98060469 |
111 | Stomach cancer (HP:0012126) | 1.97885916 |
112 | Chest pain (HP:0100749) | 1.95686354 |
113 | Persistence of primary teeth (HP:0006335) | 1.94862015 |
114 | Lymphoma (HP:0002665) | 1.94056079 |
115 | Pulmonary fibrosis (HP:0002206) | 1.92935800 |
116 | Skin rash (HP:0000988) | 1.92880809 |
117 | Premature loss of primary teeth (HP:0006323) | 1.91331980 |
118 | Osteolytic defects of the hand bones (HP:0009699) | 1.91104679 |
119 | Amaurosis fugax (HP:0100576) | 1.89177125 |
120 | Polyneuropathy (HP:0001271) | 1.85935018 |
121 | Acute hepatic failure (HP:0006554) | 1.85121129 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 4.70536912 |
2 | MAP4K1 | 3.42151490 |
3 | MAP3K13 | 3.34943522 |
4 | TYK2 | 3.29563761 |
5 | TBK1 | 3.03908327 |
6 | JAK3 | 2.98157128 |
7 | TAOK3 | 2.71057278 |
8 | IKBKB | 2.65365667 |
9 | TXK | 2.64258992 |
10 | PRPF4B | 2.60296416 |
11 | IRAK4 | 2.58088546 |
12 | IKBKE | 2.57698935 |
13 | IRAK3 | 2.39480132 |
14 | JAK1 | 2.28005118 |
15 | STK3 | 2.22588273 |
16 | BMPR2 | 2.18592158 |
17 | CHUK | 2.17190001 |
18 | BCR | 2.14731838 |
19 | TAOK2 | 2.12798287 |
20 | KIT | 2.06641903 |
21 | STK10 | 1.98209794 |
22 | EPHA3 | 1.79969998 |
23 | STK24 | 1.70387078 |
24 | RIPK4 | 1.65633753 |
25 | BLK | 1.59499534 |
26 | MAP3K11 | 1.58050061 |
27 | MAP3K10 | 1.57433761 |
28 | NLK | 1.54376871 |
29 | FGFR4 | 1.53112368 |
30 | EPHB1 | 1.52392674 |
31 | ZAP70 | 1.47230479 |
32 | NEK9 | 1.44047801 |
33 | SYK | 1.28767766 |
34 | ERN1 | 1.28432569 |
35 | BTK | 1.27921001 |
36 | PIM1 | 1.26673842 |
37 | FGFR3 | 1.23620827 |
38 | CSF1R | 1.19172776 |
39 | MOS | 1.16636501 |
40 | TEC | 1.16310653 |
41 | CSK | 1.15685211 |
42 | RPS6KA4 | 1.13212837 |
43 | EEF2K | 1.09765098 |
44 | CAMKK2 | 1.07277197 |
45 | JAK2 | 1.05177777 |
46 | LCK | 1.03141990 |
47 | HCK | 1.03022169 |
48 | MATK | 1.01779448 |
49 | ITK | 1.01533373 |
50 | MAP2K6 | 0.99085308 |
51 | NUAK1 | 0.98986173 |
52 | IRAK1 | 0.95662391 |
53 | MELK | 0.93993065 |
54 | PLK4 | 0.89301861 |
55 | GRK6 | 0.88578713 |
56 | GRK7 | 0.87878583 |
57 | CDK9 | 0.84212872 |
58 | LYN | 0.83573076 |
59 | EIF2AK3 | 0.82285679 |
60 | MAP3K6 | 0.79957500 |
61 | RAF1 | 0.78761489 |
62 | PIM2 | 0.77733931 |
63 | PTK6 | 0.74904046 |
64 | LRRK2 | 0.72998782 |
65 | MAPK11 | 0.72512293 |
66 | MARK3 | 0.68692368 |
67 | PRKAA2 | 0.68463516 |
68 | FLT3 | 0.68259369 |
69 | TRPM7 | 0.66688084 |
70 | TGFBR2 | 0.66004730 |
71 | ADRBK2 | 0.64779294 |
72 | STK4 | 0.61012440 |
73 | CDK12 | 0.59350198 |
74 | PIK3CG | 0.59014331 |
75 | TAOK1 | 0.58561018 |
76 | CDC42BPA | 0.57079303 |
77 | MAP2K3 | 0.56438438 |
78 | PRKCQ | 0.54784006 |
79 | PDK1 | 0.53418403 |
80 | ABL1 | 0.53104229 |
81 | NME2 | 0.52600326 |
82 | ARAF | 0.52007439 |
83 | CDK4 | 0.50627990 |
84 | MST4 | 0.50393902 |
85 | MAPKAPK2 | 0.49025120 |
86 | ACVR1B | 0.48394334 |
87 | SIK2 | 0.46035352 |
88 | TTK | 0.45892841 |
89 | RIPK1 | 0.45682220 |
90 | TSSK6 | 0.44458210 |
91 | DMPK | 0.44424544 |
92 | MAP3K5 | 0.43593517 |
93 | PASK | 0.43195064 |
94 | EIF2AK2 | 0.42802202 |
95 | MAP3K8 | 0.41088042 |
96 | MAP3K1 | 0.39384708 |
97 | HIPK2 | 0.39186844 |
98 | RPS6KA5 | 0.38377448 |
99 | KSR2 | 0.38220657 |
100 | MAPKAPK3 | 0.37869814 |
101 | MAP3K9 | 0.37817186 |
102 | FER | 0.36260014 |
103 | MAP3K12 | 0.35454292 |
104 | ERBB4 | 0.34965613 |
105 | IRAK2 | 0.34927263 |
106 | CDK6 | 0.31882133 |
107 | FGR | 0.31074836 |
108 | LATS1 | 0.30716543 |
109 | CAMKK1 | 0.30570599 |
110 | BMPR1B | 0.30175539 |
111 | FES | 0.29808325 |
112 | KSR1 | 0.28438886 |
113 | TGFBR1 | 0.27903330 |
114 | FRK | 0.27095241 |
115 | SIK3 | 0.26879329 |
116 | EGFR | 0.26662334 |
117 | MAPK7 | 0.26321767 |
118 | PRKCD | 0.25724010 |
119 | SMG1 | 0.25666877 |
120 | CLK1 | 0.25648308 |
121 | IGF1R | 0.24500905 |
122 | MAPKAPK5 | 0.24268209 |
123 | CDK8 | 0.23941633 |
124 | RPS6KA1 | 0.23834771 |
125 | NEK2 | 0.23824335 |
126 | MST1R | 0.23738004 |
127 | TLK1 | 0.22765158 |
128 | MAP3K3 | 0.22369333 |
129 | INSR | 0.21487045 |
130 | ALK | 0.20546708 |
131 | MAPK4 | 0.17424982 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.25082178 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.96253130 |
3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.73464111 |
4 | Allograft rejection_Homo sapiens_hsa05330 | 2.71297228 |
5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.66175638 |
6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.62074298 |
7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.53117195 |
8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.46004950 |
9 | Measles_Homo sapiens_hsa05162 | 2.41459981 |
10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.29525823 |
11 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.27401717 |
12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.24677363 |
13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.20826897 |
14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.09786398 |
15 | * TNF signaling pathway_Homo sapiens_hsa04668 | 2.08328933 |
16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.87623139 |
17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.86610797 |
18 | Legionellosis_Homo sapiens_hsa05134 | 1.82521545 |
19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.81345164 |
20 | Influenza A_Homo sapiens_hsa05164 | 1.80816810 |
21 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.79694378 |
22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.78685072 |
23 | Malaria_Homo sapiens_hsa05144 | 1.71338164 |
24 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.61477785 |
25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.59166331 |
26 | Tuberculosis_Homo sapiens_hsa05152 | 1.57182771 |
27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.53664172 |
28 | * Apoptosis_Homo sapiens_hsa04210 | 1.49764600 |
29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.48451158 |
30 | Pertussis_Homo sapiens_hsa05133 | 1.47011585 |
31 | Asthma_Homo sapiens_hsa05310 | 1.45384801 |
32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.45105217 |
33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.42896391 |
34 | Hepatitis B_Homo sapiens_hsa05161 | 1.39228237 |
35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.37820922 |
36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34303355 |
37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29878072 |
38 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.28734826 |
39 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.27011164 |
40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.23681323 |
41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.19133154 |
42 | Shigellosis_Homo sapiens_hsa05131 | 1.18747639 |
43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.16487178 |
44 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.13472604 |
45 | Hepatitis C_Homo sapiens_hsa05160 | 1.12492865 |
46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08490656 |
47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.08017432 |
48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.04275525 |
49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03786703 |
50 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.93677823 |
51 | * Small cell lung cancer_Homo sapiens_hsa05222 | 0.93513075 |
52 | Salmonella infection_Homo sapiens_hsa05132 | 0.93111863 |
53 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.88167329 |
54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85951397 |
55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.84716643 |
56 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.82346196 |
57 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75177137 |
58 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69623339 |
59 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.65506542 |
60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64463930 |
61 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64282800 |
62 | Platelet activation_Homo sapiens_hsa04611 | 0.60571953 |
63 | Amoebiasis_Homo sapiens_hsa05146 | 0.57265077 |
64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.55952721 |
65 | Colorectal cancer_Homo sapiens_hsa05210 | 0.54713289 |
66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53167171 |
67 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.51872692 |
68 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.51524091 |
69 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51419130 |
70 | Cell cycle_Homo sapiens_hsa04110 | 0.49918277 |
71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47428543 |
72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46950756 |
73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45617716 |
74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44347483 |
75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43575122 |
76 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42796582 |
77 | Lysosome_Homo sapiens_hsa04142 | 0.41717302 |
78 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41707906 |
79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41573994 |
80 | Phagosome_Homo sapiens_hsa04145 | 0.41517128 |
81 | Prostate cancer_Homo sapiens_hsa05215 | 0.40337764 |
82 | Insulin resistance_Homo sapiens_hsa04931 | 0.38842673 |
83 | Base excision repair_Homo sapiens_hsa03410 | 0.38836824 |
84 | Homologous recombination_Homo sapiens_hsa03440 | 0.38485181 |
85 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.36912996 |
86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35931110 |
87 | RNA degradation_Homo sapiens_hsa03018 | 0.35819489 |
88 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.34924351 |
89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.33286657 |
90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33285013 |
91 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33026833 |
92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32821897 |
93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30448791 |
94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29997829 |
95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29478084 |
96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.28565079 |
97 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.28326606 |
98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27773073 |
99 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.27109124 |
100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.26509450 |
101 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.26140719 |
102 | Endocytosis_Homo sapiens_hsa04144 | 0.25445907 |
103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25299663 |
104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23865270 |
105 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.23479129 |
106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.22066391 |
107 | Adherens junction_Homo sapiens_hsa04520 | 0.20659353 |
108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.20292261 |
109 | ABC transporters_Homo sapiens_hsa02010 | 0.20271332 |
110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.20152396 |
111 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.18235391 |
112 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.17651002 |
113 | Mineral absorption_Homo sapiens_hsa04978 | 0.15355950 |
114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.14268988 |
115 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.13062139 |
116 | Thyroid cancer_Homo sapiens_hsa05216 | 0.12754211 |
117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.11231959 |
118 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.07962526 |
119 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.07319831 |
120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.05711916 |
121 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.05383775 |
122 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.04936323 |
123 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.04796036 |